- The spleen as a sanctuary site for residual leukemic cells following ABT-199 monotherapy in ETP-ALL(2021)
Auteurs: Alessandra Di Grande, Sofie Peirs, Paul D. Donovan, Maaike Van Trimpont, Julie Morscio, Béatrice Lintermans, Lindy Reunes, Niels Vandamme, Steven Goossens, Hien Anh Nguyen, et al.
Pagina's: 1963 - 1976
- Targeting cytokine- and therapy-induced PIM1 activation in preclinical models of T-cell acute lymphoblastic leukemia and lymphoma(2020)
Auteurs: Renate De Smedt, Julie Morscio, Lindy Reunes, Juliette Roels, Valentina Bardelli, Béatrice Lintermans, Wouter Van Loocke, Afonso Almeida, Laurence C. Cheung, Rishi S. Kotecha, et al.
Pagina's: 1685 - 1695
- Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma(2018)
Auteurs: Renate De Smedt, Sofie Peirs, Julie Morscio, Filip Matthijssens, Juliette Roels, Lindy Reunes, Béatrice Lintermans, Steven Goossens, Tim Lammens, Nadine Van Roy, et al.
Pagina's: e17 - e20
- Targeting BET family proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia(2016)
Volume: 101
Auteurs: Sofie Peirs, Viktoras Frismantas, Filip Matthijssens, Béatrice Lintermans, Tim Pieters, Niels Vandamme, Wouter Van Loocke, Geert Berx, Bruce Poppe, Jean-Pierre Bourquin, et al.
Pagina's: 201 - 202
- Genetic characterization and therapeutic targeting of MYC translocated pediatric T-cell acute lymphoblastic leukemia(2016)
Volume: 76
Auteurs: Gloria Milani, Kaat Durinck, Filip Matthijssens, Sofie Peirs, Tim Pieters, Lindy Reunes, Béatrice Lintermans, Niels Vandamme, Tim Lammens, Yunlei Li, et al.
Aantal pagina's: 1
- The astrocytic β2-adrenergic receptor : a novel target for treatment of neuro-inflammation?(2009)
Volume: 57
Auteurs: Sarah Gerlo, Anneleen Spooren, Ron Kooijman, Béatrice Lintermans, Kathleen Van Craenenbroeck, Guy Haegeman
Pagina's: S144 - S144